Sponsor viewYour studies at a glance
Sponsor portal
Pick a study to view milestones, signed deliverables, and request updates. Studies that need your attention are highlighted.
Portfolio totals
- Studies
- 6
- Open requests
- 0
- Pending signatures
- 0
- Needs attention
- 0
Filter studies
Studies (6)
| Study | Phase | Open requests | Pending signatures | Status |
|---|---|---|---|---|
| Acme Therapeutics | ||||
| ONC-002 Relapsed/refractory multiple myeloma | Phase 2b | — | — | Active |
| Helios Cardio | ||||
| CV-118 Reduction of MACE in post-MI patients with elevated Lp(a) | Phase 3 | — | — | Active |
| Lyra Skin Sciences | ||||
| DERM-003 Moderate-to-severe atopic dermatitis (combination device) | Phase 2a | — | — | Active |
| Northwind Genetics | ||||
| RARE-007 X-linked hypophosphatemia in adults | Phase 3 | — | — | Active |
| Stellis Vaccines | ||||
| VAX-014 Respiratory syncytial virus in older adults | Phase 2b | — | — | Active |
| Veridian Pharma | ||||
| OBS-PMR-001 Long-term safety surveillance of verexitide in T2DM | Observational | — | — | Active |